Relevance of the Concept of Oncogene Addiction to Hormonal Carcinogenesis and Molecular Targeting in Cancer Prevention and Therapy
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many tumors lacking p16INK4a or overexpressing D-type cyclins have shown exquisite sensitivity to CDK4/6 inhibitors, whereas many normal cells are relatively resistant, implying that cancer cells become “addicted” to RB pathway mutations (132).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [132]
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819
Addiction to Oncogenes--the Achilles Heal of Cancer
Weinstein, I. B. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,728
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16044-3 · Cited by 1,697
Beatson, G. (1896) · The Lancet · doi:10.1016/s0140-6736(01)72384-7 · Cited by 1,608
HUGGINS, C. (1941) · Archives of Surgery · doi:10.1001/archsurg.1941.01210140043004 · Cited by 1,499
The molecular portraits of breast tumors are conserved across microarray platforms
Hu, Z., Fan, C., Oh, D. S., Marron, J., He, X., Qaqish, B. F., Livasy, C., Carey, L. A., Reynolds, E., Dressler, L., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-96 · Cited by 1,491
The changing global patterns of female breast cancer incidence and mortality
Bray, F., McCarron, P., & Parkin, D. M. (2004) · Breast Cancer Research · doi:10.1186/bcr932 · Cited by 1,007
Cited by
Targeting CDK4 and CDK6: From Discovery to Therapy
Sherr, C. J., Beach, D., & Shapiro, G. I. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0894 · Cited by 936
Targeting the DNA Damage Response in Cancer
Ljungman, M. (2009) · Chemical Reviews · doi:10.1021/cr900047g · Cited by 163
Cell Cycle–Targeted Cancer Therapies
Sherr, C. J., & Bártek, J. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-040716-075628 · Cited by 129
“However, tumor cells driven by deregulated mutant oncoproteins may become addicted to the resulting high signaling thresholds and, thus, exhibit a heightened dependency on recruited downstream signal transducers (Luo et al. 2009, Pagliarini et al. 2015, Weinstein 2008).”
BackgroundEPMA position paper in cancer: current overview and future perspectives
Grech, G., Zhan, X., Yoo, B. C., Bubnov, R. V., Hagan, S., Danesi, R., Vittadini, G., & Desiderio, D. M. (2015) · The EPMA Journal · doi:10.1186/s13167-015-0030-6 · Cited by 109
“This hypersensitivity is the basis of targeted therapies [306].”
BackgroundEstrogen receptor (ER) α mutations in breast cancer: hidden in plain sight
Fuqua, S. A. W., Gu, G., & Rechoum, Y. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2847-4 · Cited by 85
“In certain genes, activating mutations might confer enhanced sensitivity, perhaps through ‘‘addiction’’ to a specific growth or survival pathway [18].”
Background
Metadata
- Authors
- Weinstein, B.
- Affiliations
- Columbia University (US)
- Corresponding author
- Weinstein, Bernard
- Venue
- Advances in experimental medicine and biology
- Publisher
- Springer New York
- Published
- 2008
- Volume
- 617
- Pages
- 3-13
- ISSN
- 0065-2598 (ISSN-L)
- OpenAlex
- W14187310
- Cited by
- 17
- References
- 49
- Citations by year
- 2020: 2 · 2019: 2 · 2018: 1 · 2016: 3 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 1.61
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in experimental medicine and biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- oncogene addiction, hormonal carcinogenesis, breast cancer, prostate cancer, cancer prevention, molecular targeting, cancer therapy, exogenous risk factors, Westernization
- MeSH terms
- Animals, Antineoplastic Agents, Breast Neoplasms, Catechin, Female, Humans, Male, Neoplasms, Hormone-Dependent, Oncogenes, Prostatic Neoplasms, Sulindac
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Relevance of the Concept of Oncogene Addiction to Hormonal Carcinogenesis and Molecular Targeting in Cancer Prevention and Therapy. https://app.cochat.ai/papers/10.1007/978-0-387-69080-3_1
- The paper
- Weinstein, B. (2008). Relevance of the Concept of Oncogene Addiction to Hormonal Carcinogenesis and Molecular Targeting in Cancer Prevention and Therapy. Advances in experimental medicine and biology. https://doi.org/10.1007/978-0-387-69080-3_1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.